As a surrogate index of skeletal muscle mass, lower Cr/CysC may reflect muscle loss, leading to reduced insulin sensitivity, increased chronic inflammation, and ectopic lipid deposition (17–19), thereby impairing glucose homeostasis and accelerating metabolic disorders (18). This evidence concerns the gene INS and metabolic disease.